ALT vs MDLZ · rev $5.0K vs P/E 30, rev $38.54B
Altimmune Inc (ALT) versus Mondelez International Inc (MDLZ) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Latest reported ALT revenue for 2025-09-30 was $5.0K. Net income was -$60.7M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. ALT currently screens at market cap $527.0M.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
ALT currently screens at market cap $527.0M. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Not investment advice. Open the ALT and MDLZ stock pages for the full models.
Not investment advice.